東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Tailoring pharmaceutical public rela...

Wu, Xuelu.

Linked to FindBook

Google Book

Amazon

博客來

Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China./
Author:	Wu, Xuelu.
Description:	79 p.
Notes:	Source: Masters Abstracts International, Volume: 54-01.
Contained By:	Masters Abstracts International54-01(E).
Subject:	Mass communication. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1568889
ISBN:	9781321330823

Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China.
Wu, Xuelu.

Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China. - 79 p.

Source: Masters Abstracts International, Volume: 54-01.

Thesis (M.A.)--University of Southern California, 2014.

This thesis will conduct a comparative study of Merck & Co.'s launches of Gardasil in the U.S. and China. Gardasil is a vaccine for use in the prevention of certain sexually-transmitted types of human papillomavirus (HPV). It was introduced to the U.S. market in 2006 and is planned to enter Chinese market in 2014. By studying the multinational pharmaceutical company's different public relations strategies and tactics during the launches in these two countries, the author will shed light on the importance of tailoring PR strategies to different markets.

ISBN: 9781321330823Subjects--Topical Terms:

2144804
Mass communication.

Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China.
LDR:01962nmm a2200277 4500 001 2065117
005 20151130080042.5
008 170521s2014 ||||||||||||||||| ||eng d
020 $a 9781321330823
035 $a (MiAaPQ)AAI1568889
035 $a AAI1568889
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wu, Xuelu. $3 3179790
245 1 0 $a Tailoring pharmaceutical public relations strategies to different markets: A case study of the launching strategies of Gardasil in the U.S. and China.
300 $a 79 p.
500 $a Source: Masters Abstracts International, Volume: 54-01.
500 $a Adviser: Gerald Swerling.
502 $a Thesis (M.A.)--University of Southern California, 2014.
520 $a This thesis will conduct a comparative study of Merck & Co.'s launches of Gardasil in the U.S. and China. Gardasil is a vaccine for use in the prevention of certain sexually-transmitted types of human papillomavirus (HPV). It was introduced to the U.S. market in 2006 and is planned to enter Chinese market in 2014. By studying the multinational pharmaceutical company's different public relations strategies and tactics during the launches in these two countries, the author will shed light on the importance of tailoring PR strategies to different markets.
520 $a Audiences in different international markets can vary greatly depending on multiple factors, especially cultural background. China, as a typical emerging market, requires the company to make extra efforts to raise public awareness and deal with government relations due to that country's cultural and lifestyle differences and inadequate regulations. Merck & Co.'s handling of its Gardasil launches in the U.S. and China will be a good reference for other multinational companies.
590 $a School code: 0208.
650 4 $a Mass communication. $3 2144804
690 $a 0708
710 2 $a University of Southern California. $b Strategic Public Relations. $3 1024783
773 0 $t Masters Abstracts International $g 54-01(E).
790 $a 0208
791 $a M.A.
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1568889